Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2002 Jul 1;365(Pt 1):287–294. doi: 10.1042/BJ20020067

In vitro selection of fibronectin gain-of-function mutations.

Patricia H Tani 1, Joseph C Loftus 1, Ron D Bowditch 1
PMCID: PMC1222673  PMID: 12071856

Abstract

Directed protein evolution, which employs a combination of random mutagenesis, phage display, and in vitro selection, was used to identify second-site suppressors of the fibronectin (Fn) cell binding domain mutation Asp1495Ala (RGA). The mutations in the Fn 9th (3fn9) and 10th (3fn10) type III repeats obtained after selection on purified integrins alphaIIbbeta3(D119Y) and alpha5beta1 are reported. The 3fn9-10(D1495A) phage with substitution mutations at Asp1418, which is located within the linker region between 3fn9 and 3fn10, enhanced binding to the integrins alphaIIbbeta3 and alpha5beta1, but not alphavbeta3. The substitution mutations identified at residue Asp1418 were introduced into the native recombinant 3fn9-10 sequence and found to augment binding to alphaIIbbeta3, demonstrating that the observed gain-of-function phenotype was independent of the multivalent character of the phage. These results support the following conclusions. First, regions of Fn in addition to the RGD loop are in close proximity to alphaIIbbeta3 and alpha5beta1 and are capable of participating in the binding to these integrins. Secondly, the conformational relationship between the 3fn9 and 3fn10 modules may be an important factor in the binding of Fn to these two integrins. Thirdly, other altered properties of Fn-integrin interactions, such as integrin specificity, may also be selected. This is the first description of Fn mutations that augment binding to integrins. The ability to select for particular phenotypes in vitro and the subsequent characterization of these mutations should further our understanding of the molecular details involved in the association of integrins and their ligands. Additionally, these higher-affinity 3fn9-10 ligands provide a starting point for further in vitro evolution and engineering of integrin-specific modules.

Full Text

The Full Text of this article is available as a PDF (243.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aota S., Nagai T., Yamada K. M. Characterization of regions of fibronectin besides the arginine-glycine-aspartic acid sequence required for adhesive function of the cell-binding domain using site-directed mutagenesis. J Biol Chem. 1991 Aug 25;266(24):15938–15943. [PubMed] [Google Scholar]
  2. Aota S., Nomizu M., Yamada K. M. The short amino acid sequence Pro-His-Ser-Arg-Asn in human fibronectin enhances cell-adhesive function. J Biol Chem. 1994 Oct 7;269(40):24756–24761. [PubMed] [Google Scholar]
  3. Baron M., Main A. L., Driscoll P. C., Mardon H. J., Boyd J., Campbell I. D. 1H NMR assignment and secondary structure of the cell adhesion type III module of fibronectin. Biochemistry. 1992 Feb 25;31(7):2068–2073. doi: 10.1021/bi00122a025. [DOI] [PubMed] [Google Scholar]
  4. Benzer S. ON THE TOPOGRAPHY OF THE GENETIC FINE STRUCTURE. Proc Natl Acad Sci U S A. 1961 Mar;47(3):403–415. doi: 10.1073/pnas.47.3.403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bowditch R. D., Halloran C. E., Aota S., Obara M., Plow E. F., Yamada K. M., Ginsberg M. H. Integrin alpha IIb beta 3 (platelet GPIIb-IIIa) recognizes multiple sites in fibronectin. J Biol Chem. 1991 Dec 5;266(34):23323–23328. [PubMed] [Google Scholar]
  6. Bowditch R. D., Hariharan M., Tominna E. F., Smith J. W., Yamada K. M., Getzoff E. D., Ginsberg M. H. Identification of a novel integrin binding site in fibronectin. Differential utilization by beta 3 integrins. J Biol Chem. 1994 Apr 8;269(14):10856–10863. [PubMed] [Google Scholar]
  7. CRICK F. H., BARNETT L., BRENNER S., WATTS-TOBIN R. J. General nature of the genetic code for proteins. Nature. 1961 Dec 30;192:1227–1232. doi: 10.1038/1921227a0. [DOI] [PubMed] [Google Scholar]
  8. Campbell I. D., Spitzfaden C. Building proteins with fibronectin type III modules. Structure. 1994 May 15;2(5):333–337. doi: 10.1016/s0969-2126(00)00034-4. [DOI] [PubMed] [Google Scholar]
  9. Copié V., Tomita Y., Akiyama S. K., Aota S., Yamada K. M., Venable R. M., Pastor R. W., Krueger S., Torchia D. A. Solution structure and dynamics of linked cell attachment modules of mouse fibronectin containing the RGD and synergy regions: comparison with the human fibronectin crystal structure. J Mol Biol. 1998 Apr 3;277(3):663–682. doi: 10.1006/jmbi.1998.1616. [DOI] [PubMed] [Google Scholar]
  10. Dale G. L., Daniels R. B. Quantitation of immunoglobulin associated with senescent erythrocytes from the rabbit. Blood. 1991 Mar 1;77(5):1096–1099. [PubMed] [Google Scholar]
  11. Engvall E., Perlmann P. Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J Immunol. 1972 Jul;109(1):129–135. [PubMed] [Google Scholar]
  12. Forsyth J., Plow E. F., Ginsberg M. H. Fibronectin binding to platelets. Methods Enzymol. 1992;215:311–316. doi: 10.1016/0076-6879(92)15073-l. [DOI] [PubMed] [Google Scholar]
  13. Gram H., Marconi L. A., Barbas C. F., 3rd, Collet T. A., Lerner R. A., Kang A. S. In vitro selection and affinity maturation of antibodies from a naive combinatorial immunoglobulin library. Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3576–3580. doi: 10.1073/pnas.89.8.3576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Grant R. P., Spitzfaden C., Altroff H., Campbell I. D., Mardon H. J. Structural requirements for biological activity of the ninth and tenth FIII domains of human fibronectin. J Biol Chem. 1997 Mar 7;272(10):6159–6166. doi: 10.1074/jbc.272.10.6159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Grinnell F. Fibroblast receptor for cell-substratum adhesion: studies on the interaction of baby hamster kidney cells with latex beads coated by cold insoluble globulin (plasma fibronectin). J Cell Biol. 1980 Jul;86(1):104–112. doi: 10.1083/jcb.86.1.104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hawkins R. E., Russell S. J., Winter G. Selection of phage antibodies by binding affinity. Mimicking affinity maturation. J Mol Biol. 1992 Aug 5;226(3):889–896. doi: 10.1016/0022-2836(92)90639-2. [DOI] [PubMed] [Google Scholar]
  17. Hermes J. D., Blacklow S. C., Knowles J. R. Searching sequence space by definably random mutagenesis: improving the catalytic potency of an enzyme. Proc Natl Acad Sci U S A. 1990 Jan;87(2):696–700. doi: 10.1073/pnas.87.2.696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Higuchi R., Krummel B., Saiki R. K. A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Res. 1988 Aug 11;16(15):7351–7367. doi: 10.1093/nar/16.15.7351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Humphries J. D., Askari J. A., Zhang X. P., Takada Y., Humphries M. J., Mould A. P. Molecular basis of ligand recognition by integrin alpha5beta 1. II. Specificity of arg-gly-Asp binding is determined by Trp157 OF THE alpha subunit. J Biol Chem. 2000 Jul 7;275(27):20337–20345. doi: 10.1074/jbc.M000568200. [DOI] [PubMed] [Google Scholar]
  20. Kadowaki H., Kadowaki T., Wondisford F. E., Taylor S. I. Use of polymerase chain reaction catalyzed by Taq DNA polymerase for site-specific mutagenesis. Gene. 1989 Mar 15;76(1):161–166. doi: 10.1016/0378-1119(89)90018-8. [DOI] [PubMed] [Google Scholar]
  21. Kauf A. C., Hough S. M., Bowditch R. D. Recognition of fibronectin by the platelet integrin alpha IIb beta 3 involves an extended interface with multiple electrostatic interactions. Biochemistry. 2001 Aug 7;40(31):9159–9166. doi: 10.1021/bi010503x. [DOI] [PubMed] [Google Scholar]
  22. Kościelska K., Kiczak L., Kasztura M., Wesołowska O., Otlewski J. Phage display of proteins. Acta Biochim Pol. 1998;45(3):705–720. [PubMed] [Google Scholar]
  23. Lam S. C., Plow E. F., Smith M. A., Andrieux A., Ryckwaert J. J., Marguerie G., Ginsberg M. H. Evidence that arginyl-glycyl-aspartate peptides and fibrinogen gamma chain peptides share a common binding site on platelets. J Biol Chem. 1987 Jan 25;262(3):947–950. [PubMed] [Google Scholar]
  24. Leahy D. J., Aukhil I., Erickson H. P. 2.0 A crystal structure of a four-domain segment of human fibronectin encompassing the RGD loop and synergy region. Cell. 1996 Jan 12;84(1):155–164. doi: 10.1016/s0092-8674(00)81002-8. [DOI] [PubMed] [Google Scholar]
  25. Leahy D. J., Hendrickson W. A., Aukhil I., Erickson H. P. Structure of a fibronectin type III domain from tenascin phased by MAD analysis of the selenomethionyl protein. Science. 1992 Nov 6;258(5084):987–991. doi: 10.1126/science.1279805. [DOI] [PubMed] [Google Scholar]
  26. Loftus J. C., Liddington R. C. Cell adhesion in vascular biology. New insights into integrin-ligand interaction. J Clin Invest. 1997 May 15;99(10):2302–2306. doi: 10.1172/JCI119408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Loftus J. C., O'Toole T. E., Plow E. F., Glass A., Frelinger A. L., 3rd, Ginsberg M. H. A beta 3 integrin mutation abolishes ligand binding and alters divalent cation-dependent conformation. Science. 1990 Aug 24;249(4971):915–918. doi: 10.1126/science.2392682. [DOI] [PubMed] [Google Scholar]
  28. Low N. M., Holliger P. H., Winter G. Mimicking somatic hypermutation: affinity maturation of antibodies displayed on bacteriophage using a bacterial mutator strain. J Mol Biol. 1996 Jul 19;260(3):359–368. doi: 10.1006/jmbi.1996.0406. [DOI] [PubMed] [Google Scholar]
  29. Main A. L., Harvey T. S., Baron M., Boyd J., Campbell I. D. The three-dimensional structure of the tenth type III module of fibronectin: an insight into RGD-mediated interactions. Cell. 1992 Nov 13;71(4):671–678. doi: 10.1016/0092-8674(92)90600-h. [DOI] [PubMed] [Google Scholar]
  30. Mould A. P., Askari J. A., Aota S. i., Yamada K. M., Irie A., Takada Y., Mardon H. J., Humphries M. J. Defining the topology of integrin alpha5beta1-fibronectin interactions using inhibitory anti-alpha5 and anti-beta1 monoclonal antibodies. Evidence that the synergy sequence of fibronectin is recognized by the amino-terminal repeats of the alpha5 subunit. J Biol Chem. 1997 Jul 11;272(28):17283–17292. doi: 10.1074/jbc.272.28.17283. [DOI] [PubMed] [Google Scholar]
  31. Mould A. P., Askari J. A., Humphries M. J. Molecular basis of ligand recognition by integrin alpha 5beta 1. I. Specificity of ligand binding is determined by amino acid sequences in the second and third NH2-terminal repeats of the alpha subunit. J Biol Chem. 2000 Jul 7;275(27):20324–20336. doi: 10.1074/jbc.M000572200. [DOI] [PubMed] [Google Scholar]
  32. Obara M., Kang M. S., Yamada K. M. Site-directed mutagenesis of the cell-binding domain of human fibronectin: separable, synergistic sites mediate adhesive function. Cell. 1988 May 20;53(4):649–657. doi: 10.1016/0092-8674(88)90580-6. [DOI] [PubMed] [Google Scholar]
  33. Petersen T. E., Thøgersen H. C., Skorstengaard K., Vibe-Pedersen K., Sahl P., Sottrup-Jensen L., Magnusson S. Partial primary structure of bovine plasma fibronectin: three types of internal homology. Proc Natl Acad Sci U S A. 1983 Jan;80(1):137–141. doi: 10.1073/pnas.80.1.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Plow E. F., Haas T. A., Zhang L., Loftus J., Smith J. W. Ligand binding to integrins. J Biol Chem. 2000 Jul 21;275(29):21785–21788. doi: 10.1074/jbc.R000003200. [DOI] [PubMed] [Google Scholar]
  35. Rader C., Barbas C. F., 3rd Phage display of combinatorial antibody libraries. Curr Opin Biotechnol. 1997 Aug;8(4):503–508. doi: 10.1016/s0958-1669(97)80075-4. [DOI] [PubMed] [Google Scholar]
  36. Redick S. D., Settles D. L., Briscoe G., Erickson H. P. Defining fibronectin's cell adhesion synergy site by site-directed mutagenesis. J Cell Biol. 2000 Apr 17;149(2):521–527. doi: 10.1083/jcb.149.2.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Rennard S. I., Wind M. L., Hewitt A. T., Kleinman H. K. Effect of collagen and cell shape on binding of fibronectin to cells. Arch Biochem Biophys. 1981 Jan;206(1):205–212. doi: 10.1016/0003-9861(81)90082-5. [DOI] [PubMed] [Google Scholar]
  38. Sarkar G., Sommer S. S. The "megaprimer" method of site-directed mutagenesis. Biotechniques. 1990 Apr;8(4):404–407. [PubMed] [Google Scholar]
  39. Saviranta P., Pajunen M., Jauria P., Karp M., Pettersson K., Mäntsälä P., Lövgren T. Engineering the steroid-specificity of an anti-17beta-estradiol Fab by random mutagenesis and competitive phage panning. Protein Eng. 1998 Feb;11(2):143–152. doi: 10.1093/protein/11.2.143. [DOI] [PubMed] [Google Scholar]
  40. Scott J. K., Smith G. P. Searching for peptide ligands with an epitope library. Science. 1990 Jul 27;249(4967):386–390. doi: 10.1126/science.1696028. [DOI] [PubMed] [Google Scholar]
  41. Smith G. P., Scott J. K. Libraries of peptides and proteins displayed on filamentous phage. Methods Enzymol. 1993;217:228–257. doi: 10.1016/0076-6879(93)17065-d. [DOI] [PubMed] [Google Scholar]
  42. Spitzfaden C., Grant R. P., Mardon H. J., Campbell I. D. Module-module interactions in the cell binding region of fibronectin: stability, flexibility and specificity. J Mol Biol. 1997 Feb 7;265(5):565–579. doi: 10.1006/jmbi.1996.0736. [DOI] [PubMed] [Google Scholar]
  43. Xiong J. P., Stehle T., Diefenbach B., Zhang R., Dunker R., Scott D. L., Joachimiak A., Goodman S. L., Arnaout M. A. Crystal structure of the extracellular segment of integrin alpha Vbeta3. Science. 2001 Sep 6;294(5541):339–345. doi: 10.1126/science.1064535. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES